US Glutaraldehyde markets moved decisively higher in early March as trader-driven procurement and rising feedstock costs shifted sentiment from stable to bullish. Early February activity showed routine buying and balanced inventories, but by March traders hedged war-related risks and festival-driven demand, straining limited stocks. Winter weather caused minor delays, but flows were largely managed; the Glutaraldehyde uptick was driven by precautionary buying and crude-linked feedstock pressure that reshaped the balance and set an upward trajectory into March and April. Demand for Glutaraldehyde remained anchored by healthcare sterilants, oilfield biocides, and industrial water treatment, with leather and veterinary end-uses adding modest lift. Upstream cost pressure from feedstock and energy/freight supported higher domestic production economics. Domestic manufacturers maintained steady utilization with no major shutdowns, but tighter import volumes and anticipatory purchasing eroded cushions.
